Chronic inflammation's connection to atrial fibrillation points to IL-1β as a promising treatment target
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
medtechdive3d
Boston Scientific closes its year of PFA on a high note
Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...
openheart.bmj2d
Atrial fibrillation outcomes in patients from Asia and non-Asia countries: insights from GARFIELD-AF
Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...
Atrial Fibrillation Drugs Market Size to Worth USD 62.64 Billion by 2033 | Straits Research
The global atrial fibrillation drugs market size was valued at USD 24.59 billion in 2024 and is projected to reach from USD ...
Digital Health2d
Atrial fibrillation study highlights the role of GP data in research
A study led by Oxford Population Health identified 28% more cases of atrial fibrillation in primary care data than secondary care data alone.
Too Old to Operate8d
Digoxin Offers Cost Savings Over Beta-Blockers in AF Care
The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...
Everyday Health9d
Flossing Just Once a Week May Lower Stroke Risk
Flossing at least once a week may lower the risk of stroke and atrial fibrillation, according to preliminary results from a ...